The Columbus Dispatch: If abortion banned in Ohio…
UC faculty co-writes guest column on the detriments of banning abortion here
In Ohio, legislators are considering several bills, two “trigger ban” laws (Senate Bill 123 and House Bill 598) and one law that would allow private citizens to sue individuals aiding abortions (House Bill 480).
According to University of Cincinnati sociologist Danielle Bessett, who co-authored an opinion piece for The Columbus Dispatch, should Roe v. Wade be overturned by the Supreme Court, abortion trigger bans would impede abortion care for Ohioans.
The article states: In the worst-case scenario, where abortion is banned in Michigan and Pennsylvania, Ohioans would have to travel at minimum to Illinois, Maryland, or Virginia to obtain abortion care — an average driving distance of 269 miles to the nearest facility.
Danielle Bessett is an associate professor of sociology and faculty affiliate of both UC’s Women’s, Gender, and Sexuality Studies and the Medical Scientist Training Program.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.